Latest Trials Latest NewsFAQ

UNIVERSITY OF SOUTHERN CALIFORNIA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1880-01-01

Employees: 10K

Market Cap: -

Website: http://startusc.com

Clinical Trials

In-home Obesity Prevention to Reach Low-income Infants

Not Applicable

Completed

Conditions: Obesity, Childhood
Obesity
Obesity; Familial

Interventions: Behavioral: Standard HVP Curriculum
Behavioral: Obesity Prevention

First Posted Date: 2018-05-18

Last Posted Date: 2024-10-23

Lead Sponsor: University of Southern California

Target Recruit Count: 77

Registration Number: NCT03529695

Locations: 🇺🇸
University of Southern California, Los Angeles, California, United States

Gentamicin for Junctional Epidermolysis Bullosa

Phase 1

Recruiting

Conditions: Junctional Epidermolysis Bullosa

Interventions: Drug: Gentamicin Sulfate

First Posted Date: 2018-05-16

Last Posted Date: 2020-04-07

Lead Sponsor: University of Southern California

Target Recruit Count: 6

Registration Number: NCT03526159

Locations: 🇺🇸
University of Southern California, Los Angeles, California, United States

Prunes for Gastrointestinal Function After Gynecologic Surgery

Phase 4

Terminated

Conditions: Constipation

Interventions: Drug: Docusate Sodium
Dietary Supplement: Prunes

First Posted Date: 2018-05-14

Last Posted Date: 2021-04-08

Lead Sponsor: University of Southern California

Target Recruit Count: 77

Registration Number: NCT03523715

Locations: 🇺🇸
Los Angeles Count + USC Medical Center, Los Angeles, California, United States

EphB4-HSA Fusion Protein and Cytarabine /or Liposomal Vincristine in Patients With Recurrent or Refractory Acute Leukemia

Phase 1

Terminated

Conditions: Blasts 5 Percent or More of Bone Marrow Nucleated Cells
Secondary Acute Myeloid Leukemia
T Acute Lymphoblastic Leukemia
Myelodysplastic/Myeloproliferative Neoplasm
Philadelphia Chromosome Positive
Refractory Acute Myeloid Leukemia
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Recurrent Acute Lymphoblastic Leukemia
Recurrent Adult Acute Myeloid Leukemia
Refractory Acute Lymphoblastic Leukemia

Interventions: Drug: Cytarabine
Other: Laboratory Biomarker Analysis
Biological: Recombinant EphB4-HSA Fusion Protein
Drug: Vincristine Liposomal

First Posted Date: 2018-05-09

Last Posted Date: 2021-11-30

Lead Sponsor: University of Southern California

Target Recruit Count: 3

Registration Number: NCT03519984

Locations: 🇺🇸
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States

Does Timing Matter? Supporting Play, Exploration, and Early Developmental Intervention

Not Applicable

Active, not recruiting

Conditions: Preterm Infant
Cerebral Palsy

Interventions: Behavioral: Supporting Play Exploration and Developmental Intervention (SPEEDI)

First Posted Date: 2018-05-08

Last Posted Date: 2024-04-16

Lead Sponsor: University of Southern California

Target Recruit Count: 85

Registration Number: NCT03518736

Locations: 🇺🇸
University of Southern California, Los Angeles, California, United States
🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

High-Intensity Focused Ultrasound in Treating Participants With Intermediate and High-risk Prostate Cancer

Not Applicable

Withdrawn

Conditions: Prostate Cancer Stage I AJCC V6
Prostate Cancer Stage II
Prostate Cancer Stage III

Interventions: Procedure: Contrast-Enhanced Ultrasound
Device: High-Intensity Focused Ultrasound
Other: Laboratory Biomarker Analysis
Procedure: Multiparametric Magnetic Resonance Imaging
Procedure: Radical Prostatectomy

First Posted Date: 2018-05-03

Last Posted Date: 2019-08-22

Lead Sponsor: University of Southern California

Registration Number: NCT03514927

Locations: 🇺🇸
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States

Otteroo Case Series

Not Applicable

Completed

Conditions: Infants With or at Risk/Concern for Developmental Delay

Interventions: Other: Otteroo

First Posted Date: 2018-04-18

Last Posted Date: 2021-11-23

Lead Sponsor: University of Southern California

Target Recruit Count: 4

Registration Number: NCT03502265

Locations: 🇺🇸
Infant Neuromotor Control Laboratory, Los Angeles, California, United States

Collection of Blood Samples in Patients With Non-small Cell Lung Cancer

Terminated

Conditions: Stage IIIB Non-Small Cell Lung Cancer AJCC v7
Stage III Non-Small Cell Lung Cancer AJCC v7
Stage IIIA Non-Small Cell Lung Cancer AJCC v7
Stage IV Non-Small Cell Lung Cancer AJCC v7

Interventions: Procedure: Biospecimen Collection
Other: Laboratory Biomarker Analysis

First Posted Date: 2018-04-10

Last Posted Date: 2024-01-09

Lead Sponsor: University of Southern California

Target Recruit Count: 10

Registration Number: NCT03492801

Locations: 🇺🇸
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States

Collection of Blood in Studying Metabolites in Patients With Prostate Cancer

Recruiting

Conditions: Prostate Carcinoma

Interventions: Procedure: Biospecimen Collection
Other: Laboratory Biomarker Analysis

First Posted Date: 2018-04-02

Last Posted Date: 2024-03-18

Lead Sponsor: University of Southern California

Target Recruit Count: 10

Registration Number: NCT03485794

Locations: 🇺🇸
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States

Pilot Study to Examine Health Effects of Daylight Exposure on Dementia Patients

Not Applicable

Completed

Conditions: Behavior Disorders
Dementia
Depression

Interventions: Other: Daylight Intervention

First Posted Date: 2018-03-30

Last Posted Date: 2019-03-29

Lead Sponsor: University of Southern California

Target Recruit Count: 83

Registration Number: NCT03483896

Locations: 🇺🇸
Alhambra Dementia Care, Alhambra, California, United States
🇺🇸
Sierra Vista Memory Care Community, Azusa, California, United States
🇺🇸
Calabasas Memory Care Community, Calabasas, California, United States

and more 5 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy